Biocon Limited — Updates, 27-11-2024: Press Release

Biocon Biologics is advancing its collaborative project aimed at improving diabetes care in Ethiopia through the "Embedding Specialist Nurses in Diabetes Care" initiative, alongside Diabetes Africa and St Paul's Hospital Millennium Medical College. This multi-year project seeks to train nurses as diabetes specialists, addressing the critical shortage of trained healthcare professionals in the country, where diabetes prevalence is notably high.

Biocon's support underscores its commitment to enhancing healthcare access, particularly in low- and middle-income countries. The initiative aligns with the WHO's Global Diabetes Compact, aiming to integrate diabetes management into primary healthcare. With Ethiopia facing a significant healthcare challenge due to rising diabetes rates, the initiative is expected to create a sustainable framework for improving diabetes care and prevention.

This initiative presents a positive outlook for Biocon Biologics, aligning with its strategic goals of expanding access to healthcare solutions in emerging markets. Investors should watch closely as Biocon continues to strengthen its position in the global biosimilars sector while addressing critical healthcare needs.